Phase I trial of Cadherin-11 inhibitor SDP 051 in volunteers

Trial Profile

Phase I trial of Cadherin-11 inhibitor SDP 051 in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Jan 2014

At a glance

  • Drugs RG 6125 (Primary)
  • Indications Fibrosis; Rheumatoid arthritis
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Jan 2014 New trial record
    • 08 Jan 2014 Doses up to 10 mg/kg were well tolerated, according to results reported in an Adheron Therapeutics media release.
    • 08 Jan 2014 This study is recently completed, according to an Adheron Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top